Clinical Trial Update: DepoCyt for Active Lymphomatous or Leukemic Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial of DepoCyt (liposomal cytarabine) for active lymphomatous or leukemic meningitis was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Neoplastic Meningitis
• Non-hodgkin Lymphoma

Drugs mentioned

• DepoCyt (liposomal cytarabine)

Snippet

Sponsor: Duke University | Conditions: Neoplastic Meningitis, Lymphoma, B Cell | Phase 2 | Status: TERMINATED | Results posted: 2011-03-14